Telehealth has become a major source of healthcare during the Covid-19 pandemic, accounting for around 5 percent of all health insurance claims, primarily for behavioral health. However, geographical distance between patient, provider and pharmacist continues to create obstacles, especially with regard to prescriptions for controlled substances. The upcoming rules from the U.S. Drug Enforcement Administration (DEA) could potentially heighten these barriers. The ATA suggests creating a Special Registration process for remote prescribing of controlled substances to ensure prescriptions are legitimate, and a safe harbor for pharmacists dispensing remote prescriptions.
![](https://healsecurity.com/wp-content/uploads/2024/07/group-ibs-threat-intelligence-and-defence-centre-equip-undergraduates-with-sophisticated.jpg)
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some